Director Rowland Charles A Jr's Stock Transactions in Viking Therapeutics

On October 27, 2025, Rowland Charles A Jr, a director of Viking Therapeutics, Inc., engaged in multiple transactions involving the company's common stock. He acquired a total of 60,000 shares at prices ranging from $4.48 to $5.80 per share, increasing his holdings to 90,000 shares. Subsequently, he sold 60,000 shares at a weighted average price of $35.5713, reducing his holdings to 30,000 shares. Additionally, he exercised stock options for 60,000 shares, which were then sold. These transactions were reported in a Form 4 filing with the SEC.